The following page answers frequently asked questions about the PanoramaTM test.
PanoramaTM requires two cell-free DNA Streck tubes each filled with at least 10mL of the mother’s blood. See here for the sample collection instructions.
Collected samples should be stored between 43-98°F (6-37°C). Do not refrigerate or freeze collected samples – they should be stored at room temperature. See here for the sample collection instructions.
Samples can be stored briefly before shipping between 43-98°F (6-37°C), but then samples should be shipped so that they arrive at the laboratory no later than 7 days after sample collection. See here for the sample collection instructions
Click here to view a PanoramaTM sample report.
PanoramaTM Patient reports are sent via email to the email address/es indicated on the requisition form.
Please, contact your local PanoramaTM sales representative for more information.
The PanoramaTM test is the only non-invasive prenatal screening test (NIPT) that can truly distinguish between maternal and fetal DNA, giving you more accurate information about your unborn baby. Vascular Diagnostics offers a comprehensive service to all pregnant women: in addition to the most accurate NIPT available, we offer genetic counselling to all pregnant women before the test and after receiving the results, if required. We can also organise and perform a diagnostic test (amniocentesis) to confirm a high-risk test. The Panorama™ test can also be used in twin and egg donation pregnancies.
The PanoramaTM prenatal screening test offers a wide range of testing options for our patients. The basic package includes screening for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome (XXY), Jacob syndrome (XYY), Turner syndrome (X-monosomy), Triple X syndrome (XXX), triploidy, mosaicism and missing twin pregnancy, as well as determining the sex of the foetus. The microdeletion panel also includes screening for five additional microdeletion syndromes: DiGeorge, Cri-du-Chat, Prader-Willi, Angelmann and 1p36 deletion syndromes. The PanoramaTM test is also available for singleton or ovarian twin pregnancies and for pregnancies resulting from egg donation.
The PanoramaTM prenatal screening test accurately determines whether you have an identical or a twin pregnancy. In the case of monozygotic twin pregnancy, the test checks for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome (XXY), Jacob syndrome (XYY), Turner syndrome (X-monosomy), Triple X syndrome (XXX) and determines the sex of the foetus. In the case of twin pregnancy and egg donation, it tests for Down's syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau's syndrome (trisomy 13) and determines the sex of the foetuses.
The PanoramaTM prenatal screening test is highly recommended for pregnant women who are at high risk of developing one of the fetal chromosomal abnormalities tested by PanoramaTM due to a family history of accumulation or whose mother is over 35 years old. In addition, for mothers under 35 years of age and without a family history of accumulation, the test also provides important information about the fetus. The PanoramaTM is the only non-invasive (non-interventional) prenatal screening test that has been tested not only in a high risk but also in a low risk group of patients.
The PanoramaTM prenatal screening test is recommended from the 9th to the 20th week of pregnancy. The most ideal gestational age for taking the test may vary from person to person, so we recommend that you consult with our clinical geneticists or your doctor to choose the most optimal time to take the test.
A low-risk PanoramaTM test means that there is a high probability that the fetus will not be affected by the diseases being tested for.
A PanoramaTM test with a high risk means that the fetus is likely to be affected by one of the chromosomal abnormalities tested by PanoramaTM. In such a case, following a clinical genetic consultation, it is necessary to confirm the test result with a diagnostic test (amniocentesis or chorionic villus sampling). Vascular Diagnostics organises amniocentesis for all concerned, with the help of internationally recognised and respected specialists, and covers the cost of the test.
You can discuss the interpretation and significance of the disorders tested by the PanoramaTM test with our clinical geneticists. It is important in all cases to establish a family history. Our specialists can help to ensure that pregnant women are properly informed about the diseases being tested for, as well as interpreting the findings and explaining further options.
We can inform you about the PanoramaTM test results 7-10 working days after the blood sample is received in our laboratory. Deviations from this deadline may occur in rare cases, but cannot be linked to the test result.
The PanoramaTM prenatal screening test uses next-generation technology to test for a wide range of fetal chromosomal abnormalities. This technology allows the test to have an extremely high sensitivity. Both the specificity and sensitivity of the test exceed 99.99%. The PanoramaTM test has never been wrong in determining the sex of the foetus.
You can feel safe with us. Blood samples are anonymised several times over, so that no data about the mother and foetus are sent abroad that could be used to identify them. After processing, the samples are destroyed and are not used for research.
Yes, it can. The PanoramaTM test is unique in its ability to determine a fetal fraction value for both fetuses, fetal fraction is the key to accurate testing. It also determines the sex of the fetuses and whether they are monozygotic or dizygotic twins.
You can take advantage of the comprehensive service offered by the Panorama® prenatal screening test at the Vascular Diagnostics laboratory at 2/a Korányi Sándor Street, 1083 Budapest, Hungary, at the Department of Internal Medicine and Oncology or at one of our partners in Budapest or in the countryside. For further information, please click Contact us or call +36 1 755 5133.
A simple blood sample is enough for the PanoramaTM test.
A leírt teszteket a vizsgálatot végző CLIA-tanúsítvánnyal rendelkező laboratórium fejlesztette ki és teljesítményjellemzőit határozta meg. A teszteket az Egyesült Államok Élelmiszer- és Gyógyszerügyi Hatósága (FDA) nem engedélyezte vagy hagyta jóvá. Bár az FDA gyakorolja az Egyesült Államokban a forgalomba hozatal előtti felülvizsgálat és egyéb, a laboratóriumban kifejlesztett tesztekre vonatkozó szabályozások végrehajtási mérlegelési jogkörét, a CLIA értelmében a laboratórium tanúsítványa szükséges a tesztek minőségének és érvényességének biztosítása érdekében. CAP akkreditált, ISO 13485 és CLIA tanúsítvánnyal rendelkezik. © 2022 Natera, Inc. Minden jog fenntartva.